Sowell Financial Services LLC Myovant Sciences Ltd. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$17.07 - $24.56 $23,027 - $33,131	-1,349 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$20.46 - $25.18 $52,459 - $64,561	-2,564 Reduced 65.53%	1,349 $26,000
Q4 2020 Jan 13, 2021	BUY	$13.8 - $27.62 $36,901 - $73,855	2,674 Added 215.82%	3,913 $108,000
Q3 2020 Nov 12, 2020	BUY	$14.05 - $22.6 $1,166 - $1,875	83 Added 7.18%	1,239 $17,000
Q2 2020 Aug 13, 2020	SELL	$7.34 - $20.84 $27,414 - $77,837	-3,735 Reduced 76.36%	1,156 $24,000
Q1 2020 May 12, 2020	BUY	$6.55 - $14.76 $1,663 - $3,749	254 Added 5.48%	4,891 $37,000
Q4 2019 Feb 07, 2020	BUY	$4.2 - $19.21 $19,475 - $89,076	4,637 New	4,637 $71,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.